Okker D. Bijlstra
Papers
5
Total Citations
198
H-Index
5
About
Dr. Okker D. Bijlstra is a pioneering surgeon-scientist at the forefront of minimally invasive oncologic surgery, with a primary focus on fluorescence-guided imaging and robotic liver surgery. His landmark contribution is leading the AVOID trial, a multicentre, randomised, phase 3 study (84 citations) that established indocyanine green (ICG) near-infrared fluorescence as a critical tool for assessing bowel perfusion to prevent anastomotic leakage in colorectal surgery. Dr. Bijlstra has also revolutionized the surgical management of colorectal liver metastases (CRLM), demonstrating that ICG-fluorescence guidance significantly reduces unintended tumor-positive resection margins during minimally invasive procedures (49 citations). He has been instrumental in advancing robotic liver surgery in the Netherlands, publishing the first nationwide implementation and outcome data (41 citations) and developing an innovative multimodal image-guided cockpit that integrates three-dimensional liver models for enhanced surgical precision (18 citations). His systematic review on fluorescence-guided surgery for CRLM (6 citations) further underscores his role as a thought leader in the field. Dr. Bijlstra’s work bridges cutting-edge imaging technology with clinical practice, directly improving oncologic outcomes and patient safety in complex abdominal surgeries.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Implementation and Outcome of Robotic Liver Surgery in the Netherlands41 citations · 2022
- 4
- 5